Company / Debt per Share
Verrica Pharmaceuticals Inc. Debt per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.73
FY2024
5-year range
$0.73 / $1.04
FY2023-FY2024
Trend
-30.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.73 in FY2024.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, debt per share decreased 30.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.73 | -30.0% |
| FY2023 | $1.04 | - |
| FY2022 | - | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026